Published September 30, 2025 | Version v1

A review article of pharmacology of long COVID-19 and it's management

  • 1. Department of Pharmacology, Malla Reddy college of pharmacy, Osmania University, Dhulapally, Secunderabad, Telangana, 500100, India.
  • 2. Department of Pharmacy, Malla Reddy college of pharmacy, Osmania University, Dhulapally, Secunderabad, Telangana, 500100, India.

Description

A pandemic has recently been declared for COVID-19.Numerous preventive strategies and non-pharmaceutical therapies, including social distance, patient isolation, and strict infection control, have been employed to restrict the spread of disease. With oxygen therapy serving as the primary treatment intervention, management is primarily concerned with providing supportive care. Important management plans have also promoted medical treatment with corticosteroids and antivirals. Nevertheless, there is presently no vaccination for COVID-19 and no particular antiviral medication that is advised for its therapy. Even with the deliberate application of these steps, the rate of newly reported cases is still rising at a very concerning pace. We assess current knowledge on managing COVID-19 and provide an evidence-based overview of current practice as new findings become available. The number of newly reported cases is still increasing at a very concerning rate in spite of the deliberate application of these procedures. We examine current knowledge on managing COVID-19 and provide an evidence-based overview of current practice as new findings become available.

Files

WJARR-2025-2929.pdf

Files (490.1 kB)

Name Size Download all
md5:9cd5a3a2382c1d01e6fb3347d277f740
490.1 kB Preview Download

Additional details